First, we performed univariate Cox proportional hazards regression analysis, and the results showed that TNM stage and the expression of HOXA1, HOXA2, HOXA3, and HOXA4 were associated with poor outcome in cervical cancer patients (hazard ratio [HR] for T3 vs T1: 2.668 (1.149–6.194), HR for T4 vs T1: 8.093 (3.425–19.127), HR for N+ vs N−: 2.897 (1.473–5.696), HR for M+ vs M−: 3.641 (1.223–10.844), HR for HOXA1: 1.908 (1.234–2.948), HR for HOXA2: 1.659 (1.004–2.741), HR for HOXA3: 1.677 (1.112–2.526), and HR for HOXA4: 1.681 (1.023–2.763), Table 1). The gene discussed is HOXA1; the disease is cervical carcinoma.